The Multispan Difference — our collaborative approach, dedication to customer success, commitment to quality, and
breadth of assay experience & target knowledge — enables our clients to bring better medicines to market faster and
more cost-effectively by providing high quality, relevant data.
Outsourcing solutions to drive new drugs, therapies, and vaccines through the development pipeline.
Harness the power of CRISPR Engineering. Find out how Multispan solutions ensure production of high quality CRISPR tools.
Accelerating the fight against COVID 19. Find out about the foundational role of relevant, robust cell-based assays.
The power of integrating assay development and screening. Find out how Multispan solutions ensure HTS is done right.
There are 350 “druggable” GPCRs which share many similar primary and conformational epitopes. Is your antibody lead SPECIFIC to your GPCR target of interest?
Are cell culture activities holding up the development of your therapeutic? Eliminate laborious cell culture in HTS, lead optimization, and manufacturing QC.